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Effect of Ganoderma lucidum polysaccharides on the growth of 
Bifidobacterium spp. as assessed using Real-time PCR
Abstract: The use of component from Ganoderma lucidum as prebiotic source is interesting as the G. lucidum 
itself was known for more than a decade in the traditional Chinese medicine. In this work, Ganoderma lucidum 
crude polysaccharides (GLCP) and Polysaccharide-fraction number 2 (PF-2) were used as carbon sources in 
the fermentation with Bifidobacterium sp. The results showed the potential of prebiotic effect of the G. lucidum 
extract in batch-culture fermentation based on increment in the growth of bacteria used (0.4 – 1.5 log10 CFU/
mL) after 18h fermentation. Fermentation was further done using faecal materials as bacterial inocula and 
bacterial growth changes were examined using real-time PCR. The results showed the ability of GLCP and 
PF-2 to support the growth of Bifidobacterium genus with 0.3 and 0.7 log10 cells/ml increased, respectively. 
Interestingly, Lactobacillus which is known as beneficial bacterial genus also showed growth increment with 
0.7 and 1 log10 cells/ml increased. The competition for carbon sources thus inhibits the growth of potentially 
harmful genus, Salmonella (0.3 and 0.5 log10 cells/ml) in comparison to the control.  
Keywords: Ganoderma lucidum crude polysaccharides, polysaccharide-fraction number 2, Bifidobacterium 
spp., prebiotic
Introduction
Over the centuries, food for keeping a healthy 
gastrointestinal track (GIT) has evolved and risen 
into a very important issue among the public and 
researchers, in particular. Many people have gone 
beyond looking for food simply to maintain normal 
health and are seeking to optimise performance and 
wellness in addition to reducing the risk of some 
diseases such as cardiovascular disease, cancer and 
osteoporosis. This has set the scene for increased 
demand and development of functional foods 
(Delphine et al., 2009).
One of the functional foods that is increasing 
in demand is prebiotic, which has been proven 
through scientific research for its beneficial effects. 
Prebiotics are defined as “non-digestible dietary food 
ingredients that, when passing through the colon 
will benefit the host by selectively stimulating the 
growth and/or activity of one or a limited number of 
beneficial bacteria in situ” (Gibson and Roberfroid, 
1999). Prebiotics provide food for the growth of 
lactobacilli and bifidobacteria. These non-fermentable 
carbohydrates can be found naturally not only in 
cereals such as wheat and oat, but even in garlic, 
chicory and artichokes. However, their quantity 
is present in small amounts. Fruit and vegetables 
are among the most common, available and easily 
obtained prebiotic in the diet. Although it is preferable 
to obtain prebiotics from natural sources, this may not 
always be practical. Prebiotics can be incorporated 
into the diet through foods such as cereals and dairy 
products. Direct consumption of prebiotics is already 
available in the market in the capsule form. 
New research is being proposed to find and 
establish new prebiotics synchronised with the 
demands of the market and people. The potential of 
polysaccharides from mushroom is a growing interest 
among researchers. Polysaccharides from Pleurotus 
ostreatus and Pleurotus eryngii were reported to 
be able to support the growth of Lactobacillus sp. 
(Andriy et al., 2009). Thus, interest was increased on 
the potential of Ganoderma lucidum, the well-known 
medical fungi as prebiotic. The G. lucidum mushroom 
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contains pharmacologically active variables and the 
constituents of G. lucidum include polysaccharides 
(including beta-D-glucans, heteropolysaccharides 
and glycoproteins), triterpines, germanium, essential 
and non-essential amino acids, sterols, lipids, anti-
oxidants, vitamins B1, B2, B6, iron, calcium, and 
zinc (Huie, 2004; McKenna, 2002). This mushroom 
has been reported to be effective in the treatment of 
chronic hepatopathy, hypertension, hyperglycaemia 
and neophasia (Franz, 1989; Furusawa et al., 
1992; Shiao et al., 1994). The polysaccharides 
were also reported to have anti-tumour properties 
(Miyazaki and Nishijima, 1981; Wang et al., 1997) 
and hypoglycaemic activities (Hikino et al., 1985; 
Tomoda et al., 1986).
Thus, this study was conducted in order to 
determine the ability of oligosaccharides from 
Ganoderma lucidum crude polysaccharide (GLCP) 
extract and second fraction of polysaccharide 
fractions (PF-2) to selectively promote the growth 
of Bifidobacterium strains and reveal the effect of 
GLCP and PF-2 as prebiotic towards the bacterial 
microflora in human faeces.
Materials and Methods
Ganoderma lucidum extract preparation
The dried fruit bodies of G. lucidum were purchased 
from Malimas Healthcare Sdn. Bhd. (Selangor, 
Malaysia). The polysaccharides from fruiting bodies 
were extracted and fractionated according to Bao et al. 
(2002) with some modifications. Briefly, the fruiting 
bodies were boiled and fractionated with DEAE-
cellulose column, eluted with H2O and followed 
by 0.005, 0.2, 0.5 M NaCl solutions at a flow rate 
of 1.0 mL/min. The fractions were collected and 
separated based on the NaCl solutions concentration 
to have four fractions namely; PF-1, PF-2, PF-3 
and PF-4. Fractionation was performed for several 
times and fractions with the same elution times were 
pooled together. PF-2 was the only fraction used to 
further the tests because of its potential in supporting 
bifidobacterial growth (Mohd Hamim, 2009). PF-2 
was kept in 4°C. Fructooligosaccharides (FOS) 
was used as prebiotic control obtained from Orafti 
(Teinen, Belgium).
Proximate analysis of GLCP
Proximate analysis of GLCP was carried 
out according to AOAC method (1995). 
Moisture, protein, ash and crude fiber contents 
were analysed. Total carbohydrate contents 
were determined in percent by the formula, 
[100% − (%protein + %fat + %ash + %moisture)]. 
Determination of growth rates and survival of 
bacteria in GLCP and PF-2
The growth of B. pseudocatenulatum G4, 
B. longum BB536 and B. breve ATCC 15700 on 
glucose, GLCP and PF-2 was examined using batch 
culture fermentation. The bacteria were grown in the 
1L bioreactor (B. Braun, France) for 24h in 37ºC. 
Sampling was done for every 6h. Growth rates and 
the ability of bacteria to grow in GLCP and PF-2 
were observed. Glucose was used as the control.
Determination of prebiotic ability of GLCP and 
PF-2 in faecal culture
Fresh voided faecal samples were collected in 
sterile plastic bags, and kept cool in insulated boxes 
until they were transferred to the laboratory where they 
were immediately analysed. Faecal slurry inoculum 
was prepared 1h prior to fermentation. Fresh faecal 
samples were collected from three healthy people who 
practiced normal Malaysian diet and did not take any 
probiotic supplements or any antibiotics for 3 months 
before sampling. Faecal samples (10 g) from each 
person were mixed and homogenised in 300 mL of 
0.1 M phosphate-buffered saline (PBS), pH 7.0 (10% 
w/v).  Then, the faecal slurry was filtered using metal 
sieve to discard food and solid particles from inoculum 
suspension. All the procedures were done in laminar 
flow to prevent any contamination from undesirable 
outside microorganisms. Four types of carbon sources 
namely glucose, FOS, GLCP and PF-2 were added to 
anaerobic faecal batch cultures separately and ran for 
24h fermentation. The effects upon major groups of 
the microbiota namely Bifibacterium, Lactobacillus, 
Bacteroides and Salmonella genus were evaluated 
using real-time PCR. The temperature of bioreactor 
was maintained for 37°C along the fermentation 
process to simulate human body temperature for 
optimum bacterial growth. 
Quantitative real-time PCR
Cell concentration in fermentation samples was 
determined using molecular method. Duplication 
samples from fermentation bottles (2 mL each) were 
taken after 12 h and 24 h of fermentation and were 
stored at −20°C. After the extraction of DNA, 4 genera 
and species of predominant bacteria in human GIT 
namely Bifidobacterium, Lactobacillus, Bacteroides, 
and Salmonella were detected and quantified 
using quantitative real-time PCR method. The cell 
concentration in the samples was determined using 
standard curves generated from known concentration 
of plasmid DNA that carried the targeted gene for 
each genus and species. Quantification of four 
genera of bacteria in fermentation products was 
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achieved by using standard curves made from known 
concentrations of plasmid DNA containing the 
respective amplicon for each set of primers (Fite et 
al., 2004). The real-time PCR machine generated 
standard curve automatically by using the standard 
plasmid DNA and specific primers for each bacterial 
genus and species.  Standard curves for quantification 
of number of cells in samples were generated using 
known concentration of plasmid DNA containing 
target gene. Plasmid DNA that was previously 
extracted from competent cells was measured for 
its concentration (g/µL) using spectrophotometry 
method at the absorbance of 260 nm. Then, the 
plasmid DNA was serially diluted (10-fold) until five 
times before 5 µL from each dilution were mixed with 
PCR mixture. The target genes were amplified by real-
time PCR using the same primers in triplicate. The 
concentration of plasmid DNA was converted from 
g/µL in stock solution to copies/µL in PCR mixture. 
PCR amplification were performed using primers 
Forward 5’-CTCCTGGAAACGGGTGG-3’ and 
Reverse 5’-GGTGTTCTTCCCGATATCTACA-3’ 
for Bifidobacterium genus (Matsuki et al., 2003), 
Forward 5’-TGGAAACAGGTGCTAATACCG-3’ 
and Reverse 5’-CCATTGTGGAAGATTCCC-3’ 
for Lactobacillus genus (McOrist et al., 2002), 
Forward 5’-TCCACCTGGGGAGTACGCCG-3’ and 
Reverse 5’-TATGGCACTTAAGCCGACACC-3’ 
for Bacteriodes genus (McOrist et al., 2002) and 
Forward 5’- ACAGCAAAATGCGGATGCTTT-3’ 
and Reverse 5’-GAGCGCTCAGTGTAGGACTC 
-3’ for Salmonella genus (Carlson et al., 1999), to 
amplify 16S rRNA  genes in this selected bacteria. 
Determination of specificity for each primer set and 
the optimum annealing temperature was done using 
a BiometraTM T Gradient thermocycler (Biometra, 
Goettingen, Germany). The primers were synthesised 
commercially by First BASE Laboratories Sdn. Bhd. 
(Selangor, Malaysia). Real-time PCR amplification 
for the detection and enumeration of bacterial DNA 
was performed in a computer-operated Rotorgene 
3000 real-time PCR system from Corbett Research, 
Australia. SYBR green master mix (Qiagen, USA) 
was used as a reporter dye in real-time PCR assay. 
The DNA template that had already been extracted 
from fermentation sample was mixed with other 
real-time PCR components in one 0.2 mL PCR tube 
before analyzed using real-time PCR machine. 
Organic acid analysis 
Profiles of SCFA were analysed by high-
performance liquid chromatography (HPLC) 
(Shimadzu LC-10AS Liquid Chromatography, Japan) 
with a Shimadzu SPD-10AV UV-VIS detector. An 
organic column packed with 9 µm of polystyrene 
divinylbenzene ion exchange resin (Aminex HPX-
87H; 300 mm × 7.8 mm, Bio-Rad Laboratories, USA) 
and maintained at 65°C was used. The UV detector 
was set at 220 nm and the mobile phase was 0.009 N 
sulphuric acid with a flow rate of 0.7 ml/min.
Statistical analysis 
Data analysis was done using MINITAB version 14 
(Minitab Inc., PA, United States). Differences between 
growth rate constants were checked by ANOVA 
for pure culture fermentation. Differences between 
bacterial counts at 0, 18 and 24 h of fermentation for 
each batch culture, treatments, and concentration of 
organic acids were checked for significance by paired 
t-test, assuming equal variances and considering both 
sides of distribution. A probability of P<0.05 was 
used as criterion for statistical significance.
Result and Discussion
The composition analysis of the GLCP
The yield of hot water extracts for G. lucidum 
shows that the carbohydrates (polysaccharides) was 
the highest (82.2%), while ash was the lowest (1.5%). 
The yield of protein, fat and moisture were 3.6, 4.3 
and 8.4 percent, respectively. The fractionation 
process produced four types of fractions known as 
polysaccharides fraction one (PF-1), polysaccharides 
fraction two (PF-2), polysaccharides fraction three 
(PF-3) and polysaccharides fraction four (PF-4) as 
shown in Figure 1. However, based on the previous 
experiment, PF-2 was the only fraction selected for 
further experiment because of its ability to maintain 
and support the growth of Bifidobacterium sp. in the 
previous studies (Mohd Hamim, 2009). 
Figure 1. DEAE–cellulose elution profile of the polysaccharides present in the aqueous extract 
of Ganoderma lucidum fruit bodies. The column was eluted stepwise with H2O, 0.05, 0.1, 0.2 
and 0.5 M NaCl solutions. PF-2 was used in the further fermentations (marked with the box).
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Fermentation of GLCP and PF-2 in pure culture
Polysaccharides from mushroom were found to be 
able to induce the growth of probiotic bacteria. Andriy 
et al. (2009) reported that polysaccharides from 
Pleurotus ostreatus and Pleurotus eryngii supported 
the growth of Lactobacillus strains. The research has 
proven the ability of polysaccharides from mushroom 
to act as prebiotics. In this study, polysaccharides 
from Ganoderma lucidum extract were able to 
increase the growth of three selected Bifidobacterium 
strains. GLCP are first polysaccharides produced 
through extraction and purification. Based on Fig. 
2, bacterial were shown of optimum growth at 18h 
and slightly reduced after 24h. At 18h, GLCP was 
shown slight increase in the bacterial growth for B. 
pseudocatenulatum G4, B. longum BB536, B. breve 
ATCC 15700 with 0.69, 0.59 and 0.53 log10 CFU/
ml, respectively when compared to initial inoculums. 
The increase was because of the present of simple 
sugar such as glucose, in the crude extract (GLCP) 
itself.  The present of simple sugar was also found 
in crude extract from several previous researches 
such as Saidou et al. (2011) with 22-36 percent of 
glucose from local African legumes. In the algal 
researches by Attachai and Anong (2010), glucose 
ranged within 0.09 to 0.45 percent was detected. The 
natural quantity after being extracted in the crude 
extract was the cause for the differences in glucose 
composition. As for PF-2, the sugar was produced 
through fractionation process. Fermentation of PF-2 
was shown increase in the growth of Bifidobacterium 
strains (1.42, 1.61 and 1.73 log10 CFU/ml) compared 
to the initial inoculums. In comparison to FOS, the 
difference in bacterial growth for PF-2 at 18h was 
between 0.9 – 1.6 log10 CFU/ml for those three types 
of Bifidobacterium strains. 
As for commercial prebiotic, FOS seems to have 
the ability to increase the growth of Bifidobacterium 
strains higher than GLCP and PF-2 with maximum 
growth at 18 h with range 2.6 to 3 log10 fold 
bacterial count. As for B. longum BB536, when 
the fermentation reached 18 h, the growth of this 
bacterium seemed to increase and managed to reach 
9.94 log10 CFU/ml in FOS, respectively at the end of 
24 h fermentation. Extended fermentation might be 
necessary to observe carbon source depletion point 
for this particular bacterium. Based on the growth 
profiles of Bifidobacterium strains, all strains were 
able to consume and degrade the component of crude 
GLCP and PF-2. As for G. lucidum, polysaccharides 
that are beneficial to human are also beneficial to 
Bifidobacterium strains from the perspective of this 
research. 
From the Figure 2, all of the Bifidobacterium 
strains used possessed a different growth rate in 
the fermentation process with glucose, FOS, GLCP 
or PF-2 as their carbon sources. The growth rates 
of Bifidobacterium strains were determined by the 
ability to ferment each carbon sources and degree of 
polymerisation (DP) structure as Bifidobacterium sp. 
preferred to use low-DP carbohydrates (Cummings 
et al., 2001). From the three strains assessed, the best 
growth rates belonged to B. pseudocatenulatum G4 in 
FOS. FOS has the lowest DP structure among these 
four carbon sources. Even though the Bifidobacterium 
strains gave different log numbers of bacteria when 
grown in different types of prebiotics and carbon 
sources, the growth patterns were almost the same 
as they consumed the carbon sources on the same 
biochemical pathway. 
Fermentation of GLCP and PF-2 in human faecal 
culture 
Fermentation of polysaccharides in faecal cultures 
was conducted to show the prebiotic capabilities 
on all Bifidobacterium strains. The changes in cell 
number of bacteria were monitored using real-time 
PCR analysis. The fermentations were performed 
in the bioreactor with faecal slurry as the bacterial 
inoculum. Initial numbers of bacteria were different 
from each other with the highest being Bacteriodes 
with 7.4 log10 cells/ml, followed by Bifidobacterium, 
Lactobacillus and Salmonella with concentrations 
at 7.2, 6.5, and 2.8 log10 cells/ml, respectively. In 
these fermentations, the ability of bacteria to use 
carbon sources was shown with differences in the 
increment of bacterial cell numbers. Using real-time 
PCR analysis, the numbers of bacteria will be shown 
merely increment in the results as the machine will 
calculate not only alive but also dead bacteria. 
In the human gut, bacterial composition changes 
according to daily diet taken by the host. FOS was 
proven to be able to increase Bifidobacterium genus 
(Bouhnik et al., 1996) thus giving a better gut health to 
the host. Based on Table 1, all selected carbon sources 
were able to increase the number of Bifidobacterium 
genus with the range between 0.3 log10 cells/ml to 
1.1 log10 cells/ml. In the prebiotic treatment, the 
increase in the growth of the bacteria tested could 
be seen with significant numbers ranging from 
0.6 log10 cell/ml to 1.8 log10 cell/ml after 24 h of 
fermentation. GLCP and PF-2 that were chosen to be 
prebiotics candidates were able to increase the growth 
of total Bifidobacterium genus by 0.3 log10 cell/ml 
and 0.7 log10 cells/ml, respectively. The increase of 
Bifidobacterium genus showed significant difference 
(P≤0.05) in PF-2 at 24 h when compared to the initial 
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count. However, no significant difference (P>0.05) 
could be seen for GLCP and PF-2 when compared 
to the control. On the other hand, the increase of cell 
number for Lactobacillus genus was interestingly 
higher compared to Bifidobacterium genus with 0.7 
log10 cells/ml for GLCP and 1 log10 cells/ml for 
PF-2. Lactobacillus is known for its beneficial effects 
and most of the probiotics come from this genus. The 
increase of Lactobacillus was significantly different 
(P≤0.05) when compared to the initial count of cell 
numbers with the highest growth at 1.8 log10 cells/ml 
in FOS. The increase was even higher as compared to 
Bifidobacterium genus thus showing their ability to 
be better at fermenting polysaccharides. Bacteriodes 
also showed an increase in FOS, GLCP and PF-2. 
However, the increase was far too low when compared 
to the control. Thus, it could be concluded that 
Bacteriodes does not prefer to use a FOS, GLCP and 
PF-2 as a carbon source. The inhibition of Salmonella 
was clearly shown in the FOS and PF-2 treatment. 
The inhibition of potential pathogenic bacteria 
fulfilled one of the prebiotic criteria. As the increase 
of Bifidobacterium and Lactobacillus in GLCP and 
PF-2 media was not as significantly (P>0.05) high as 
in FOS, the ability of GLCP and PF-2 to support the 
growth of those bacteria increases the expectation for 
a new prebiotic source. 
Organic acids production
Acetic acid and lactic acid are two types of 
main organic acids produced by Bifidobacterium 
genus in ratio 3 to 2. In this research, the ability of 
Bifidobacterium genus in fermenting GLCP and PF-2 
were shown by quantity of organic acid produced 
along their fermentation process (Table 2).  The 
production of organic acids was in line with the 
Glu-P, FOS-P, GLCP-P, PF-2-P = Carbon sources used for fermentation of B. pseudocatenulatum G4; Glu-L, FOS-L, GLCP-L, PF-2-L = Carbon sources used for fermentation of B. longum 
BB536; Glu-B, FOS-B, GLCP-B, PF-2-B = Carbon sources used for fermentation of B. breve ATCC 15700. Data are expressed as mean±standard error (N=3).
Figure 2. Growth of Bifidobacterium spp. in different types of carbon sources in faecal batch culture fermentation
Table 2. Production of lactic acid and acetic acid in batch cultures fermentation of human 
faecal microbiota and significant difference between GLCP and PF-2 with glucose (control) 
and FOS (prebiotic control).
a Significantly different from Control (P≤0.05) with higher value
b Significantly different from Control (P≤0.05) with lower value
A Significantly different from FOS (P≤0.05) with lower value
Table 1. Changes in bacterial population (log10 cells/ml) in batch cultures 
after 12 h and 24 h of incubation using real-time PCR based on total 
number of cells (viable and dead). 
N0 = Initial inoculum
a Significantly different from initial count (P≤0.05) at 0h
A Significantly different from glucose (P≤0.05) with higher value
B Significantly different from glucose (P≤0.05) with lower value
Values are mean log10 cells/ml culture ± SD for three replicates. 
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growth of Bifidobacterium genus which shown 
the high numbers of this bacteria in faecal batch 
fermentation. Organic acid also one of the factors 
identified in inhibiting pathogenic bacteria in several 
researches. In the research by Midolo et al. (2005), 
the high concentration of organic acid was reported 
to be able to inhibit the growth of pathogenic bacteria 
in the gut such as Helicobacter pylori. In this study, 
the primers used for quantification using real-time 
PCR assay were counting both the dead and alive 
bacteria thus only increases of bacteria could be seen. 
Therefore, the inhibition of Salmonella genus only 
could be seen by comparing the growth of Salmonella 
genus in glucose medium with the other carbon 
sources containing media. From Table 1, the cell 
number of Salmonella genus was slightly increased 
or in same numbers as initial inoculums. When 
compared to the glucose (control), the difference was 
between 0 to 0.1 log10 cells/ml which resulted from 
the inability of Salmonella genus to grow in GLCP and 
PF-2 and thus can be concluded that the Salmonella 
growth was inhibited. The inhibition of Salmonella 
sp. by Bifidobacterium sp. was also shown by Araya-
Kojima et al. (1995) by administration of B. longum 
BB536. 
Conclusion
Fermentation of Ganoderma lucidum extracts 
have shown prebiotic ability of polysaccharides 
in increasing the number of bifidobacteria. The 
increase in the number of Lactobacillus, which is 
also well-known for its probiotic capability, should 
be considered as part of success in this study. The 
production of organic acid during prebiotic treatments 
showed domination of Bifidobacterium species 
throughout the fermentation process. The pattern of 
its production and inhibition of potential pathogenic 
bacteria suggest that the organic acids might directly 
confer antimicrobial action. 
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